Nisha Patel, NP | |
10861 Cherry St Ste 104, Los Alamitos, CA 90720-5403 | |
(562) 794-9801 | |
Not Available |
Full Name | Nisha Patel |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 10861 Cherry St Ste 104, Los Alamitos, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083369151 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 95262590 (California) | Secondary |
363LF0000X | Nurse Practitioner - Family | NP95020607 (California) | Primary |
Entity Name | Prohealth Partners, A Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003949975 PECOS PAC ID: 2769388412 Enrollment ID: O20031211000927 |
News Archive
The medical technology developed by Integrated Medical Systems, Inc., has been recognized by the U.S. Department of Health and Human Services and the U.S. Treasury Department as a "qualified therapeutic discovery." The designation earns the company a grant to off-set its development efforts. The Qualifying Therapeutic Discovery Project designation and grant is provided for under the Patient Protection and Affordable Care Act of 2010.
Researchers at UCLA's Jonsson Comprehensive Cancer Center created a large, well armed battalion of tumor-seeking immune system cells and watched, in real time using Positron Emission Tomography (PET), as the special forces traveled throughout the body to locate and attack dangerous melanomas.
Using whole genomic sequencing, scientists from RIKEN in Japan have for the first time demonstrated the profound effect that chronic hepatitis infection and inflammation can have on the genetic mutations found in tumors of the liver, potentially paving the way to a better understanding of the mechanisms through which these chronic infections can lead to cancer.
Women who have surgery for their prolapse have a 3 in 10 chance of needing at least one more operation, so the success rate is not great. Gynecologists hoped that using non-absorbable synthetic mesh or biological graft material as a patch to reinforce their standard repairs, the success rate would get better.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Nisha Patel, NP 10861 Cherry St Ste 104, Los Alamitos, CA 90720-5403 Ph: (562) 794-9801 | Nisha Patel, NP 10861 Cherry St Ste 104, Los Alamitos, CA 90720-5403 Ph: (562) 794-9801 |
News Archive
The medical technology developed by Integrated Medical Systems, Inc., has been recognized by the U.S. Department of Health and Human Services and the U.S. Treasury Department as a "qualified therapeutic discovery." The designation earns the company a grant to off-set its development efforts. The Qualifying Therapeutic Discovery Project designation and grant is provided for under the Patient Protection and Affordable Care Act of 2010.
Researchers at UCLA's Jonsson Comprehensive Cancer Center created a large, well armed battalion of tumor-seeking immune system cells and watched, in real time using Positron Emission Tomography (PET), as the special forces traveled throughout the body to locate and attack dangerous melanomas.
Using whole genomic sequencing, scientists from RIKEN in Japan have for the first time demonstrated the profound effect that chronic hepatitis infection and inflammation can have on the genetic mutations found in tumors of the liver, potentially paving the way to a better understanding of the mechanisms through which these chronic infections can lead to cancer.
Women who have surgery for their prolapse have a 3 in 10 chance of needing at least one more operation, so the success rate is not great. Gynecologists hoped that using non-absorbable synthetic mesh or biological graft material as a patch to reinforce their standard repairs, the success rate would get better.
› Verified 1 days ago